Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Beneficial effect of etidronate therapy in immobilized hip fracture patients.

Sato Y, Kanoko T, Yasuda H, Satoh K, Iwamoto J.

Am J Phys Med Rehabil. 2004 Apr;83(4):298-303.

PMID:
15024332
[PubMed - indexed for MEDLINE]
2.

Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.

Sato Y, Iwamoto J, Honda Y.

J Stroke Cerebrovasc Dis. 2010 May;19(3):198-203. doi: 10.1016/j.jstrokecerebrovasdis.2009.04.006.

PMID:
20434046
[PubMed - indexed for MEDLINE]
3.

Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.

Sato Y, Asoh T, Kaji M, Oizumi K.

J Bone Miner Res. 2000 Dec;15(12):2487-94.

PMID:
11127214
[PubMed - indexed for MEDLINE]
4.

[Immobilization and hip fracture].

Sato Y.

Clin Calcium. 2006 Dec;16(12):1991-98. Review. Japanese.

PMID:
17142929
[PubMed - indexed for MEDLINE]
5.

Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.

Sato Y, Honda Y, Iwamoto J.

Neurology. 2007 Mar 20;68(12):911-5.

PMID:
17372126
[PubMed - indexed for MEDLINE]
6.

Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.

Sato Y, Iwamoto J, Kanoko T, Satoh K.

Mov Disord. 2006 Jul;21(7):924-9.

PMID:
16538619
[PubMed - indexed for MEDLINE]
7.

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.

Sato Y, Iwamoto J, Kanoko T, Satoh K.

Arch Intern Med. 2005 Aug 8-22;165(15):1743-8.

PMID:
16087822
[PubMed - indexed for MEDLINE]
8.

A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.

Kushida K, Fukunaga M, Kishimoto H, Shiraki M, Itabashi A, Inoue T, Kaneda K, Morii H, Nawata H, Yamamoto K, Ohashi Y, Orimo H.

J Bone Miner Metab. 2004;22(5):469-78.

PMID:
15316868
[PubMed - indexed for MEDLINE]
9.

Risedronate therapy for prevention of hip fracture after stroke in elderly women.

Sato Y, Iwamoto J, Kanoko T, Satoh K.

Neurology. 2005 Mar 8;64(5):811-6.

PMID:
15753414
[PubMed - indexed for MEDLINE]
10.

Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial.

Sato Y, Honda Y, Iwamoto J.

Bone. 2006 Nov;39(5):1080-6. Epub 2006 Jun 14.

PMID:
16777503
[PubMed - indexed for MEDLINE]
11.

A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.

Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ.

Am J Med. 1999 May;106(5):513-20.

PMID:
10335722
[PubMed - indexed for MEDLINE]
12.

Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: a randomized, double blind, controlled trial.

Fokter SK, Komadina R, Repse-Fokter A.

Wien Klin Wochenschr. 2006;118 Suppl 2:23-8.

PMID:
16817039
[PubMed - indexed for MEDLINE]
14.

The effect of short-term calcitonin administration on biochemical bone markers in patients with acute immobilization following hip fracture.

Tsakalakos N, Magiasis B, Tsekoura M, Lyritis G.

Osteoporos Int. 1993 Dec;3(6):337-40.

PMID:
8292845
[PubMed - indexed for MEDLINE]
15.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
16.

Effects of intravenous etidronate disodium on skeletal and calcium metabolism.

Kanis JA, Urwin GH, Gray RE, Beneton MN, McCloskey EV, Hamdy NA, Murray SA.

Am J Med. 1987 Feb 23;82(2A):55-70.

PMID:
3103437
[PubMed - indexed for MEDLINE]
17.

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.

Sato Y, Kanoko T, Satoh K, Iwamoto J.

Arch Intern Med. 2005 Aug 8-22;165(15):1737-42.

PMID:
16087821
[PubMed - indexed for MEDLINE]
18.

Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM; Research Committee of the British Thoracic Society.

Thorax. 2004 Sep;59(9):761-8.

PMID:
15333852
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.

Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.

Transpl Int. 2009 Feb;22(2):198-206. doi: 10.1111/j.1432-2277.2008.00763.x. Epub 2008 Sep 15. Erratum in: Transpl Int. 2009 Jun;22(6):679. Torne, Santiago [corrected to Tome, Santiago].

PMID:
18796000
[PubMed - indexed for MEDLINE]
20.

Hip fractures in users of first- vs. second-generation bisphosphonates.

Mamdani M, Kopp A, Hawker G.

Osteoporos Int. 2007 Dec;18(12):1595-600. Epub 2007 Sep 1.

PMID:
17767369
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk